Home   About this service   Get the news  
+32 2 743 34 03

 Belgium  Other Countries
Page : 1 - 2 - ... 8 - 9 - 10 - 11 - 12 - 13 - 14 - ...
UCB [BE0003739530/UCB]   

UCB : UCB Media Room

UCB’s Key Pipeline Molecule Bimekizumab Demonstrated Improved Outcomes for Ankylosing Spondylitis PatientsNew Phase 2b bimekizumab data showed the novel investigational molecule delivered improvements in disease activity and in important patientreported outcomes, such as pain, fatigue, morning stiffness, function and quality of life for patients with ankylosing spondylitis.Improvements are... See more
UCB [BE0003739530/UCB]   

UCB : UCB Media Room: Transparency Notification

Transparency notifications BlackRock, Inc.Notifications referring to situation on 5 June 2019 and 7 June 2019Threshold crossed: 5%Latest holding: 5.23%Brussels Belgium, 12 June 2019 – 20:00 CEST – regulated information1. Summary of the notificationsPursuant to Article 14 of the law of 2 May 2007 on the disclosure of large shareholdings, UCB SA/NV announces that it has received two... See more
D'IETEREN [BE0974259880/DIE]   

D'IETEREN : Repurchase of own shares in the context of the liquidity contract

PRESS RELEASE: REPURCHASE OF OWN SHARES IN THE CONTEXT OF THE LIQUIDITY CONTRACT REGULATED INFORMATION Wednesday 12 June 2019 – 6:00 pm Repurchase of own shares in the context of... See more
UCB [BE0003739530/UCB]   

UCB : UCB Media Room

UCB Showcases the Depth of its Immunology Research and Commitment to Patientsat EULAR 2019Three oral presentations on novel investigational molecule bimekizumab to show potential for improving disease activity and quality of life outcomes in patients with ankylosing spondylitis, and musculoskeletal and skin outcomes over 48 weeks in those with psoriatic arthritisMultiple presentations will... See more

ECONOCOM GROUP : Calendrier de paiement du remboursement de prime d’émission à hauteur de 0,12 euro par action

communiqué de presse Information réglementée 06 juin 2019 L'Assemblée Générale Extraordinaire réunie le 21 mai 2019 a approuvé le remboursement de prime d'émission assimilée à du capital libéré d'un montant de 0,12 euro par action. Ce remboursement interviendra pour toute action existante à la date de détachement du coupon. Conformément à l'article 613 du Code...